Epitomee Medical Receivables

The latest receivables for EPIT.TA is $1.5M as of June 2026. That compares with $1.1M in the prior-year period — up 43.6% year over year. Investors often review this figure alongside Epitomee Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, EPIT.TA's receivables moved from $1.1M to $1.5M — a 43.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Epitomee Medical's operating scale or balance-sheet position.

A receivables figure of $1.5M for EPIT.TA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting EPIT.TA's receivables ($1.5M), review year-over-year change from $1.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.